• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种 Fc 工程改造方法,用于鉴定针对埃博拉病毒的体液免疫功能相关因素。

A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus.

机构信息

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.

Department of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX, USA; Galveston National Laboratory, Galveston, TX, USA.

出版信息

Immunity. 2021 Apr 13;54(4):815-828.e5. doi: 10.1016/j.immuni.2021.03.009.

DOI:10.1016/j.immuni.2021.03.009
PMID:33852832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8111768/
Abstract

Protective Ebola virus (EBOV) antibodies have neutralizing activity and induction of antibody constant domain (Fc)-mediated innate immune effector functions. Efforts to enhance Fc effector functionality often focus on maximizing antibody-dependent cellular cytotoxicity, yet distinct combinations of functions could be critical for antibody-mediated protection. As neutralizing antibodies have been cloned from EBOV disease survivors, we sought to identify survivor Fc effector profiles to help guide Fc optimization strategies. Survivors developed a range of functional antibody responses, and we therefore applied a rapid, high-throughput Fc engineering platform to define the most protective profiles. We generated a library of Fc variants with identical antigen-binding fragments (Fabs) from an EBOV neutralizing antibody. Fc variants with antibody-mediated complement deposition and moderate natural killer (NK) cell activity demonstrated complete protective activity in a stringent in vivo mouse model. Our findings highlight the importance of specific effector functions in antibody-mediated protection, and the experimental platform presents a generalizable resource for identifying correlates of immunity to guide therapeutic antibody design.

摘要

保护性埃博拉病毒 (EBOV) 抗体具有中和活性,并诱导抗体恒定区 (Fc) 介导的先天免疫效应功能。增强 Fc 效应功能的努力通常侧重于最大限度地提高抗体依赖性细胞毒性,然而,对于抗体介导的保护作用,不同的功能组合可能是至关重要的。由于已经从埃博拉病毒病幸存者中克隆出了中和抗体,因此我们试图确定幸存者的 Fc 效应功能谱,以帮助指导 Fc 优化策略。幸存者发展出了一系列功能性抗体反应,因此我们应用了一种快速、高通量的 Fc 工程平台来定义最具保护作用的功能谱。我们从一种埃博拉病毒中和抗体中生成了具有相同抗原结合片段 (Fab) 的 Fc 变体文库。具有抗体介导的补体沉积和适度自然杀伤 (NK) 细胞活性的 Fc 变体在严格的体内小鼠模型中表现出完全的保护活性。我们的研究结果强调了特定效应功能在抗体介导的保护中的重要性,并且该实验平台为鉴定免疫相关性提供了一种普遍适用的资源,以指导治疗性抗体设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/8111768/4708dd303d70/nihms-1687054-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/8111768/43088636ec99/nihms-1687054-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/8111768/9ed1de582d28/nihms-1687054-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/8111768/38ee59174686/nihms-1687054-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/8111768/4708dd303d70/nihms-1687054-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/8111768/43088636ec99/nihms-1687054-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/8111768/9ed1de582d28/nihms-1687054-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/8111768/38ee59174686/nihms-1687054-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/8111768/4708dd303d70/nihms-1687054-f0005.jpg

相似文献

1
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus.一种 Fc 工程改造方法,用于鉴定针对埃博拉病毒的体液免疫功能相关因素。
Immunity. 2021 Apr 13;54(4):815-828.e5. doi: 10.1016/j.immuni.2021.03.009.
2
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus.Fc 功能在治疗性单克隆抗体预防埃博拉病毒中的作用。
Cell Host Microbe. 2018 Aug 8;24(2):221-233.e5. doi: 10.1016/j.chom.2018.07.009.
3
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors.抗体 Fc 介导的效应功能与埃博拉病毒幸存者长期后遗症之间的关联。
Front Immunol. 2021 May 20;12:682120. doi: 10.3389/fimmu.2021.682120. eCollection 2021.
4
Differential requirements for FcγR engagement by protective antibodies against Ebola virus.保护性抗埃博拉病毒抗体对 FcγR 结合的差异需求。
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20054-20062. doi: 10.1073/pnas.1911842116. Epub 2019 Sep 4.
5
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.Fc 介导的呼吸道合胞病毒感染和疾病中的抗体效应功能。
Front Immunol. 2019 Mar 22;10:548. doi: 10.3389/fimmu.2019.00548. eCollection 2019.
6
Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine.额外的中和 FcR 介导的抗体功能用于通用流感疫苗。
Front Immunol. 2019 Mar 18;10:440. doi: 10.3389/fimmu.2019.00440. eCollection 2019.
7
Cell-targeting antibodies in immunity to Ebola.埃博拉免疫中的细胞靶向抗体。
Pathog Dis. 2016 Jun;74(4):ftw021. doi: 10.1093/femspd/ftw021. Epub 2016 Mar 21.
8
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization.治疗性抗体鸡尾酒分析揭示了协同和广谱埃博拉病毒中和的决定因素。
Immunity. 2020 Feb 18;52(2):388-403.e12. doi: 10.1016/j.immuni.2020.01.001. Epub 2020 Feb 4.
9
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein.多功能 Pan-埃博拉病毒抗体识别埃博拉病毒糖蛋白上的广泛脆弱位点。
Immunity. 2018 Aug 21;49(2):363-374.e10. doi: 10.1016/j.immuni.2018.06.018. Epub 2018 Jul 17.
10
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.埃博拉病毒糖蛋白 Fc 融合蛋白赋予接种疫苗的小鼠免受致死性挑战的保护。
Vaccine. 2011 Apr 5;29(16):2968-77. doi: 10.1016/j.vaccine.2011.01.113. Epub 2011 Feb 15.

引用本文的文献

1
Single-dose replicon RNA Sudan virus vaccine uniformly protects female guinea pigs from disease.单剂量复制子RNA苏丹病毒疫苗能一致地保护雌性豚鼠免受疾病侵害。
Nat Commun. 2025 May 6;16(1):4199. doi: 10.1038/s41467-025-59560-1.
2
A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults.一位隐藏的守护者:中国成年人新冠病毒感染反应中抗体依赖的细胞介导细胞毒性作用的稳定性及范围
Vaccines (Basel). 2025 Feb 28;13(3):262. doi: 10.3390/vaccines13030262.
3
Combinatorial Fc modifications for complementary antibody functionality.

本文引用的文献

1
Human neutralizing antibodies elicited by SARS-CoV-2 infection.SARS-CoV-2 感染诱导的人体中和抗体。
Nature. 2020 Aug;584(7819):115-119. doi: 10.1038/s41586-020-2380-z. Epub 2020 May 26.
2
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.来自马尔堡感染幸存者的非中和抗体通过 Fc 效应功能介导保护,并增强其他抗体的效力。
Cell Host Microbe. 2020 Jun 10;27(6):976-991.e11. doi: 10.1016/j.chom.2020.03.025. Epub 2020 Apr 21.
3
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
用于互补抗体功能的组合Fc修饰
MAbs. 2025 Dec;17(1):2465391. doi: 10.1080/19420862.2025.2465391. Epub 2025 Feb 14.
4
With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process.能力越大,责任越大:在抗体研发过程早期广泛衡量Fc介导的效应子功能的重要性。
MAbs. 2025 Dec;17(1):2453515. doi: 10.1080/19420862.2025.2453515. Epub 2025 Jan 16.
5
Underappreciated layers of antibody-mediated immune synapse architecture and dynamics.抗体介导的免疫突触结构与动力学中未被充分认识的层面。
mBio. 2025 Jan 8;16(1):e0190024. doi: 10.1128/mbio.01900-24. Epub 2024 Dec 11.
6
Post-COVID immunity in patients with solid tumor or hematological malignancies treated with SARS-CoV-2 monoclonal antibodies.接受SARS-CoV-2单克隆抗体治疗的实体瘤或血液系统恶性肿瘤患者的新冠后免疫力
Immun Inflamm Dis. 2024 Dec;12(12):e70039. doi: 10.1002/iid3.70039.
7
Transforming vaccinology.疫苗学的变革。
Cell. 2024 Sep 19;187(19):5171-5194. doi: 10.1016/j.cell.2024.07.021.
8
Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement.感染过程中的Fc-FcγR相互作用:从中和抗体到抗体依赖增强作用
Immunol Rev. 2024 Nov;328(1):221-242. doi: 10.1111/imr.13393. Epub 2024 Sep 13.
9
Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis.工程化抗体促进中性粒细胞依赖控制结核分枝杆菌。
Nat Microbiol. 2024 Sep;9(9):2369-2382. doi: 10.1038/s41564-024-01777-9. Epub 2024 Aug 22.
10
A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus.一种利用卡介苗免疫既往史的病毒疫苗设计可预防埃博拉病毒。
Front Immunol. 2024 Jul 16;15:1429909. doi: 10.3389/fimmu.2024.1429909. eCollection 2024.
抗体依赖增强作用促进冠状病毒进入的分子机制。
J Virol. 2020 Feb 14;94(5). doi: 10.1128/JVI.02015-19.
4
Differential requirements for FcγR engagement by protective antibodies against Ebola virus.保护性抗埃博拉病毒抗体对 FcγR 结合的差异需求。
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20054-20062. doi: 10.1073/pnas.1911842116. Epub 2019 Sep 4.
5
A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation.一种高通量、基于珠粒的抗原特异性测定法,用于评估抗体诱导补体激活的能力。
J Immunol Methods. 2019 Oct;473:112630. doi: 10.1016/j.jim.2019.07.002. Epub 2019 Jul 10.
6
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses.埃博拉病毒病幸存者产生多功能抗体反应。
J Infect Dis. 2020 Jan 1;221(1):156-161. doi: 10.1093/infdis/jiz364.
7
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.Fc 介导的呼吸道合胞病毒感染和疾病中的抗体效应功能。
Front Immunol. 2019 Mar 22;10:548. doi: 10.3389/fimmu.2019.00548. eCollection 2019.
8
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.抗刺突 IgG 通过在急性 SARS-CoV 感染期间使巨噬细胞反应发生偏斜,导致严重的急性肺损伤。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.123158.
9
NK Cells Activated through Antibody-Dependent Cell Cytotoxicity and Armed with Degranulation/IFN-γ Production Suppress Antibody-dependent Enhancement of Dengue Viral Infection.自然杀伤细胞通过抗体依赖性细胞毒性被激活,并具有脱颗粒/IFN-γ产生能力,可抑制登革热病毒感染的抗体依赖性增强作用。
Sci Rep. 2019 Feb 1;9(1):1109. doi: 10.1038/s41598-018-36972-2.
10
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.两株抗体泛埃博拉病毒鸡尾酒疗法在雪貂和非人灵长类动物中提供广泛的治疗保护。
Cell Host Microbe. 2019 Jan 9;25(1):49-58.e5. doi: 10.1016/j.chom.2018.12.005.